APA

Isaacs J. T., Pili R., Qian D. Z., Dalrymple S. L., Garrison J. B., Kyprianou N., Björk A., Olsson A. & Leanderson T. (20070116). Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer. : The Prostate.

Chicago

Isaacs John T, Pili Roberto, Qian David Z, Dalrymple Susan L, Garrison Jason B, Kyprianou Natasha, Björk Anders, Olsson Anders and Leanderson Tomas. 20070116. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer. : The Prostate.

Harvard

Isaacs J. T., Pili R., Qian D. Z., Dalrymple S. L., Garrison J. B., Kyprianou N., Björk A., Olsson A. and Leanderson T. (20070116). Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer. : The Prostate.

MLA

Isaacs John T, Pili Roberto, Qian David Z, Dalrymple Susan L, Garrison Jason B, Kyprianou Natasha, Björk Anders, Olsson Anders and Leanderson Tomas. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer. : The Prostate. 20070116.